Pharmafile Logo
Pharmafocus logo
Advanced Search
alzheimers

Roche’s experimental Alzheimer’s drug does not meet primary endpoint in clinical trials

February 10, 2020
Sales and Marketing Alzheimer's, Roche, roche Alzheimer

Roche has said its experimental drug, gantenerumab, did not meet its primary endpoint in people who have an inherited form …

News
screenshot-2019-06-27-at-13

Nanoform establishes US subsidiary

February 10, 2020
Sales and Marketing nano, nano science, nanotech

Nanoform has set up an American subsidiary, ‘Nanoform USA’, due to increasing demand for the companies CESS technology.Its patented CESS …

News
absent_nasal_bone

FDA approves Caption Health’s AI-guided imaging system

February 10, 2020
Sales and Marketing AI, Caption Health, FDA, ultrasound, ultrasound imaging

The FDA have given marketing approval for Caption Health’s Caption Guidance and its use in cardiac ultrasound images.The technology allows …

News
6507102201_ab7cda0ed0_b

Several European cases of coronavirus traced to ski resort in the Alps

February 10, 2020
Sales and Marketing china coronavirus, coronavirus, vietnam coronavrisu, wuhan cornavirus

Multiple European cases of coronavirus have been traced to a ski resort in the Alps, with a British man spread …

News

Vietnam develops quick coronavirus test kit

February 10, 2020
Sales and Marketing Wuhan Coronavirus, china coronavirus, coronavirus, vietnam, vietnam coronavirus

Researchers in Vietnam have developed a coronavirus test kit which provides results in 70 minutes instead of four hours like …

News
1740294_bertil-lindmark-webbnyhet

Galecto hires new Chief Medical Officer

February 7, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Galecto

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.Lindmark joins …

Appointment
rob_van_maanen

New Chief Medical Officer joins Khondrion

February 7, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Khondrion has revealed that Dr Rob van Maanen has joined the company as its new Chief Medical Officer (CMO). Dr …

Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 7, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MERS, Sars, china coronavirus, coronavirus, coronavirus China, wuhan coronaviurs

The Wuhan coronavirus continues to dominate the news, with China admitting its handling of the crisis had shortcomings while Gilead …

News
shutterstock_349943306

85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds

February 7, 2020
Medical Communications, Research and Development clinical trials, pharma

Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …

News
army_trainers_teach_nhs_medics_how_to_put_on_ebola_safety_suits_15650293350

Third person in the UK diagnosed with coronavirus

February 7, 2020
Medical Communications China, Coronavirus Wuhan, MERS, Sars, coronavirus, coronavirus China

A third British person has been diagnosed with the coronavirus, which he allegedly  caught in Singapore.He was tested in Brighton …

News
gsk_boronia_australia

GSK to axe 720 positions at Belgian vaccine facility

February 7, 2020
Manufacturing and Production, Medical Communications GSK, job cuts, pharma

GlaxoSmithKline has announced a cull of staff at its vaccine production site in Belgium, with 720 employees facing the axe. …

News
26795063175_fe37f336f7_b

Jury orders Johnson & Johnson to pay $750 million in latest baby powder case

February 7, 2020
Medical Communications J&J, JJ, Johnson & Johnson, ovarian cancer, talc, talc powder

Johnson & Johnson have been ordered to pay by a jury $750 million to four plaintiffs over the company’s baby …

News
abbvie_0

AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3

February 6, 2020
Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis

AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …

News
quarterlife

Virus DNA found in cancer cells

February 6, 2020
Business Services Cancer, Cancer Virus, HPV, cancer research

The first comprehensive survey of viruses found with different types of cancer has been conducted by researchers. Researchers from the …

News
laboratory-analysis-diagnostics-hospital

Landmark study set to transform cancer treatment

February 6, 2020
Business Services Cancer, cancer breast, cancer mutations, cancer research, cancer treatment

Over a thousand scientists have built the most detailed picture of cancer ever in a landmark study. Their research was …

News
shutterstock_274590824

Biogen stock surges following patent victory over Mylan for Tecfidera

February 6, 2020
Sales and Marketing Biogen, Mylan, multiple sclerosis, pharma, tecfidera

Biogen has emerged victorious in a patent dispute with Mylan relating to the latter’s multiple sclerosis therapy Tecfidera – a …

News
small-1908307_1280

Newborn baby diagnosed with coronavirus

February 6, 2020
Business Services China disease, Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

A baby born this month in Wuhan China has been diagnosed with the coronavirus. The child was born 2 February, …

News

How AI is making clinical trials more accurate and affordable

February 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …

Feature

NICE plans to use broader range of data in guidance

February 5, 2020
Research and Development NHS, NHS NICE, NICE

The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …

News

Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study

February 5, 2020
Research and Development Bayer, Eylea, pharma

Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026